Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Curis initiated with a Buy at H.C. Wainwright » 06:04
11/24/20
11/24
06:04
11/24/20
06:04
CRIS

Curis

$1.35 /

+0.055 (+4.25%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRIS Curis
$1.35 /

+0.055 (+4.25%)

CRIS Curis
$1.35 /

+0.055 (+4.25%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.35 /

+0.055 (+4.25%)

Yesterday
Conference/Events
Curis management to meet virtually with Cantor Fitzgerald » 04:55
11/23/20
11/23
04:55
11/23/20
04:55
CRIS

Curis

$1.30 /

+ (+0.00%)

Virtual Meeting to be…

Virtual Meeting to be held on November 23 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
CRIS Curis
$1.30 /

+ (+0.00%)

CRIS Curis
$1.30 /

+ (+0.00%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.30 /

+ (+0.00%)

Friday
Conference/Events
Curis management to meet virtually with Cantor Fitzgerald » 12:02
11/20/20
11/20
12:02
11/20/20
12:02
CRIS

Curis

$1.30 /

+ (+0.00%)

Virtual Meeting to be…

Virtual Meeting to be held on November 23 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
CRIS Curis
$1.30 /

+ (+0.00%)

CRIS Curis
$1.30 /

+ (+0.00%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.30 /

+ (+0.00%)

Over a week ago
Earnings
Curis reports Q3 EPS (11c), consensus (13c) » 16:28
11/10/20
11/10
16:28
11/10/20
16:28
CRIS

Curis

$1.16 /

+0.09 (+8.41%)

Reports Q3 revenue $2.7M,…

Reports Q3 revenue $2.7M, consensus $2.57M. As of September 30 Curis' cash, cash equivalents, marketable securities and investments totaled $23.6M and there were approximately 56.7M shares of common stock outstanding. Curis expects that its existing cash, cash equivalents and investments should enable it to maintain its planned operations through the Q2 of FY21. "We have continued to advance our clinical programs towards important catalysts at the end of this year and into 2021, which we expect to be another important year of data for Curis," said James Dentzer, President and CEO. "We have been pleased with the enrollment progress of our first-in-class IRAK4 inhibitor, CA-4948, in a Phase 1 study in patients with non-Hodgkin's lymphoma, and we look forward to providing an update at ASH. We began a second Phase 1 study for patients with relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS) and we are pleased to announce today a CRADA with the NCI for further development of CA-4948 as an anti-cancer agent. We also look forward to initiating our Phase 1 combination study evaluating CA-4948 and the BTK inhibitor, ibrutinib, in patients with NHL, including those with MYD88 altered disease."

ShowHide Related Items >><<
CRIS Curis
$1.16 /

+0.09 (+8.41%)

CRIS Curis
$1.16 /

+0.09 (+8.41%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.16 /

+0.09 (+8.41%)

Earnings
Curis reports Q3 EPS (11c), consensus (13c) » 16:12
11/10/20
11/10
16:12
11/10/20
16:12
CRIS

Curis

$1.14 /

+0.07 (+6.54%)

Reports Q3 revenue $2.7M,…

Reports Q3 revenue $2.7M, consensus $2.57M.

ShowHide Related Items >><<
CRIS Curis
$1.14 /

+0.07 (+6.54%)

CRIS Curis
$1.14 /

+0.07 (+6.54%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.14 /

+0.07 (+6.54%)

Over a month ago
Hot Stocks
Curis' CA-4948 shows IRAK4 inhibition in published study » 08:08
10/21/20
10/21
08:08
10/21/20
08:08
CRIS

Curis

$1.18 /

-0.005 (-0.42%)

Curis highlighted a paper…

Curis highlighted a paper published online in ACS Medicinal Chemistry Letters, a peer-reviewed publication of the American Chemical Society, which describes the preclinical work done to select CA-4948 and its on-target engagement and inhibition of IRAK4 in various animal studies. CA-4948 demonstrated 'potent' IRAK4 inhibition, with favorable selectivity over other kinases, cellular activity, pharmacokinetics, efficacy, and safety, and showed tumor regression in a diffuse large B-cell lymphoma xenograft model without any overt toxicities. The company expects to provide an update of clinical results for this program later this quarter. CA-4948 is a small molecule inhibitor of IRAK4, which is currently being tested in a Phase 1 dose escalating clinical trial in patients with non-Hodgkin lymphomas. CA-4948 is also being investigated in a separate Phase 1 trial for acute myeloid leukemia and myelodysplastic syndromes. The company is planning a combination study of CA-4948 and ibrutinib, a BTK inhibitor, in non-Hodgkin lymphomas with planned enrollment commencing in Q4.

ShowHide Related Items >><<
CRIS Curis
$1.18 /

-0.005 (-0.42%)

CRIS Curis
$1.18 /

-0.005 (-0.42%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.18 /

-0.005 (-0.42%)

Conference/Events
Curis management to meet virtually with Needham » 04:55
10/15/20
10/15
04:55
10/15/20
04:55
CRIS

Curis

$1.31 /

+0.035 (+2.75%)

Virtual Meeting to be…

Virtual Meeting to be held on October 15 hosted by Needham.

ShowHide Related Items >><<
CRIS Curis
$1.31 /

+0.035 (+2.75%)

CRIS Curis
$1.31 /

+0.035 (+2.75%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.31 /

+0.035 (+2.75%)

Hot Stocks
Curis announces abstract for CI-8993 accepted at SITC » 17:05
10/14/20
10/14
17:05
10/14/20
17:05
CRIS

Curis

$1.31 /

+0.035 (+2.75%)

Curis announced that a…

Curis announced that a Trial in Progress abstract for CI-8993, a first-in-class monoclonal anti-VISTA antibody, has been accepted for poster presentation at the Society for Immunotherapy of Cancer's, or SITC, 35th Anniversary Annual Meeting, which will be held virtually from November 9-14, 2020.

ShowHide Related Items >><<
CRIS Curis
$1.31 /

+0.035 (+2.75%)

CRIS Curis
$1.31 /

+0.035 (+2.75%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.31 /

+0.035 (+2.75%)

Conference/Events
Curis management to meet virtually with Needham » 11:46
10/13/20
10/13
11:46
10/13/20
11:46
CRIS

Curis

$1.22 /

-0.01 (-0.81%)

Virtual Meeting to be…

Virtual Meeting to be held on October 15 hosted by Needham.

ShowHide Related Items >><<
CRIS Curis
$1.22 /

-0.01 (-0.81%)

CRIS Curis
$1.22 /

-0.01 (-0.81%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.22 /

-0.01 (-0.81%)

Over a quarter ago
Conference/Events
Curis management to meet virtually with Needham » 04:55
08/14/20
08/14
04:55
08/14/20
04:55
CRIS

Curis

$1.26 /

-0.01 (-0.79%)

Virtual Meeting to be…

Virtual Meeting to be held on August 14 hosted by Needham.

ShowHide Related Items >><<
CRIS Curis
$1.26 /

-0.01 (-0.79%)

CRIS Curis
$1.26 /

-0.01 (-0.79%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Cantor Fitzgerald
Curis nearing inflection point, says Cantor Fitzgerald, initiates at Overweight
CRIS Curis
$1.26 /

-0.01 (-0.79%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.